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Abstract
Objective. To estimate the burden of diarrhea-associated hospital
izations among children in Hawaii.
Design Retrospective analysis of hospital discharge records.
Patients. Children from 1 month through 4 years of age with a
diarrhea-associated diagnosis listed on the hospital discharge
record in Hawaii.
Setting. Acute care hospitals in the state of Hawaii, 1994 through
1997.
Results. During 1994-1997, 2288 children (11.3% of all hospitaliza
tions for children < 5 years of age) had a diarrhea-associated
diagnosis listed at hospital discharge. The average annual Thci
dence (per 10,000 children) ofdiarrhea-associated hospitalizations
was 62.3; the incidence was higher forchildren < 1 year(101.6) than
for those 1 through 4 years of age (52.7). Rates for Hawaii were
lower than national rates during 1993 through 1995 (US annual rate
of 89 per 10,000 children). The median length of hospital stay was
2 days for diarrhea-associated hospitalizations, and 3 days for
hospitalizations specifically associated with rota virus-related diar
rhea. Diarrhea-associated hospitalizations were highest during the
period December through June.
Conclusions. Diarrhea is an important cause of hospitalization
among children in Hawai where approximately 1 in 32 children may
be hospitalized by 5 years of age. The age-specific and temporal
trends reported here are consistent with those previously described
forrota virus-associatedhospitalizations, suggesting thatthispatho
gen is a major contributor to the overall morbidity from diarrhea.
Introduction
Diarrheal illnesses cause about 150,000 - 170,000 hospitalizations
per year among US children under 5 years of age, accounting for
approximately 12% of all hospitalizations in this age group.1’2
Rotavirus is the most common pathogen detected in etiologic studies
ofUS children hospitalized with diarrhea.3’4However, this pathogen
is not routinely tested for in children with diarrhea because such
testing adds cost without significantly altering treatment. Conse
quently, estimates of the morbidity from rotavirus-associated hospi
talizations are not readily available. Previous studies have sug
gested that the unique epidemiologic features of rotavirus (i.e.,
winter seasonality, predisposition for children 4-35 months of age)
can be used to estimate the morbidity from this pathogen by using
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nonspecific data on diarrhea in children.”2’5-9These indicators were
used in this study to estimate the morbidity associated with rotavirus
diarrhea among children in Hawaii by analyzing data on diarrhea-
associated hospitalizations.
Methods
Hospital discharge data for the period 1994 through 1997 were
obtained from the Hawaii Health Information Corporation (HHIC),’°
a non-profit corporation that collects discharge information from all
acute care hospitals in the State of Hawaii. Patient records are
processed through a comprehensive error identification and correc
tion process, and annual hospitalization records are available for
analysis within the following year.
Hospital discharge data were examined for children 1 month
through 4 years of age who had an International Classification of
Diseases, 9th revision, Clinical Modification (ICD-9-CM) code for
diarrhea listed as one ofup to 10 diagnoses on the discharge record.”
The ICD-9-CM codes used included diarrhea of determined etiol
ogy (bacterial [001 to 005, 008.0-008.5, excluding 003.21, viral
[008.6-008.81, and parasitic [006-007, excluding 006.3-006.61) and
diarrhea of undetermined etiology, including those presumed to be
infectious (009.0-009.3) and noninfectious (558.9, 787.91).
Rotavirus-associated hospitalizations were defined by the specific
ICD-9-CM code 008.61, which was introduced in October 1992.
Neonates were excluded from the analysis because the ICD-9-CM
classifies diarrheal illness in these infants with distinct neonatal
codes.
Data were examined for trends in hospitalizations for diarrhea and
for rotavirus by age, sex, season, and etiology. Data on race were
unavailable. Hospitalization rates (per 10,000 children) were calcu
lated by using the census state population of children for the
corresponding age group (<1 year, 1-4 years, and <5 years of age).’2
Risk ratios (RRs) with 95% confidence intervals (CIs) were calcu
lated using Poisson regression analysis.’3Hospital length ofstay was
compared using the Wilcoxon rank-sum test.
Results
A total of 2288 diarrhea-associated hospitalizations were reported
among children 1 month through 4 years of age in Hawaii during the
4-year study period (Table 1), accounting for 11.3% of all hospital
izations among <5-year-old children. Hospitalizations for children
1-11 months of age accounted for 32.0% of the diarrhea-associated
hospitalizations for all children 1 month through 4 years old (Figure
1). Most (73.6%) diarrhea-associated hospitalizations were of
unspecified etiology; ofthe remaining, viruses accounted for 21.4%,
followed by bacteria (5.9%) and parasites (0.3%).
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Table 1. Diarrhea-associated hospitalizations among
children 1-59 months of age in Hawaii, by diagnostic
category, 1994-1997.
Rotavirus 008.61
008.6, 489 (21.4)
008.8
001-005.9,
008-008.5
001-001.9 0 (0.0)
002-003.9 48 (2.1)
19 (0.8)
17 (0.7)
008.008.5 53 (2.3)
Total 2288 (100)
* More than one diagnostic category (ICD-9-CM code) may be
listed on each discharge record.
t Excludes localized salmonella infections (003.2).
4 Excludes amebic liver abscess (006.3), amebic lung abscess
(006.4), amebic brain abscess (006.5), and amebic skin
ulceration
(006.6).
The average annual incidence of diarrhea-associated hospitaliza
tions among children 1 month through 4 years of age was 62.3 per
10,000. The incidence varied by year from 49.8 per 10,000 in 1994
to 70.1 per 10,000 in 1995, and no well-defined trend was observed
(Figure 2). The average annual incidence was greater among infants
than among children aged 1-4 years (101.6 per 10,000 [N = 733]
compared with 52.7 per 10,000 [N=1555], respectively, RR = 1.9,
95% Cl = 1.8 - 2.1) and among males than among females (66.7 per
10,000 [N = 1259] compared with 57.7 per 10,000 [N = 1028],
respectively, RR = 1.2,95% CI = 1.1 - 1.3). The median duration of
a diarrhea-associated hospitalization was 2 days. Two deaths were
reported among the 2288 hospitalizations with diarrhea.
A diagnosis of rotavirus diarrhea was coded on 2.1% (N = 47) of
all discharges for diarrhea, increasing from 1.3% in 1994 after the
introduction of the new rotavirus-specific ICD-9-CM code to 3.5%
in 1997. The incidence of hospitalizations coded as rotavirus diar
rhea was not significantly greater among infants than among chil
dren aged 1-4 years (19.4 per 10,000 [N = 14] compared with 11.2
per 10,000 [N = 33], respectively, RR = 1.7,95% CI = 0.9-3.2), and
was similar among males and females (14.3 per 10,000 [N = 27]
compared with 11.2 per 10,000 [N = 201, respectively, RR = 1.3,
95% CI = 0.7 -2.3). The median duration of a rotavirus-associated
hospitalization was greater than that of hospitalizations for diarrhea
of other etiologies (3 days compared with 2 days, respectively, p <
.001).
Diagnostic Category * ICD-9-CM
Codes
No. (%)
Etiology Unspecified
Presumed infectious
Presumed noninfectious
Etiology Specified
Viral
009-009.3
558.9,
787.91
19 (0.8)
1684 (73.6)
Figure 1.— Diarrhea-associated hospitalizations and cumulative
percent hospitalizations by age in months among children 1 month
through 4 years of age in Hawaii, 1994 through 1997.
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Figure 2.— Diarrhea-associated hospitalizations and hospitalization
rates by year and age group among children 1 month through 4 years
of age in Hawaii, 1994 through 1997.
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When diarrhea-associated hospitalizations were examined by
month of admission, an increase was observed in the months of
December through June each year (Figure 3). Examination of the
composite monthly number of diarrhea-associated hospitalizations
by age-group and etiology identified several trends (Figure 4). By
age-group, the seasonal peak in diarrhea-associated hospitalizations
was most prominent for children 4-35 and 36-59 months of age, but
was not seen in children 1-3 months ofage (Figure 4A). By etiology,
the seasonal peak in diarrhea-associated hospitalizations was most
noticeable for those of viral and presumed non-infectious etiologies
and was not seen among those of other etiologies (Figure 4B).
Discussion
Diarrhea remains an important cause of morbidity among children
in Hawaii. If each child is admitted for diarrhea only once, this
would mean that, on average, 1 of every 32 children is hospitalized
for diarrhea by the age of 5 years. The winter seasonality ofdiarrhea-
associated hospitalizations, most prominent among children 4-59
months of age, is consistent with the epidemiologic characteristics
of rotavirus and likely reflects hospitalizations caused by this
pathogen. However, only a small fraction (— 2%) of diarrhea-
associated hospitalizations were coded specifically as rotavirus,
possibly because of under-diagnosis and under-reporting. These
findings are consistent with those of other studies based on national
and state data on diarrhea-associated hospitalizations among chil
dren and demonstrate the importance of rotavirus as a cause of
severe diarrhea in US children.”2’5-9
While this study provides useful estimates of the morbidity from
rotavirus diarrhea among children in Hawaii, it has several limita
tions. First, because information about outpatient visits and emer
gency room admissions was not examined, this study presents a
limited picture of the total morbidity associated with rotavirus
diarrhea among children Hawaii. Second, because data on hospital
ization costs were not available, no assessment was made of the
economic burden of hospitalizations associated with rotavirus diar
rhea. Third, because only limited diagnosis-specific information
about rotavirus diarrhea was available, the morbidity associated
with rotavirus-associated hospitalizations among children in Ha
waii could not accurately ascertained. A more comprehensive and
accurate assessment of the disease burden of rotavirus diarrhea in
Hawaii could be obtained through a network of sentinel hospitals in
which every child admitted with diarrhea and a representative
sample of children who visit the emergency room and outpatient
clinics for a diarrheal illness is tested for rotavirus and information
about the costs associated with these events is gathered.
A rotavirus vaccine that is approximately 80% efficacious against
rotavirus-associated hospitalizations was licensed in 1998 for use in
the United States and was recommended in 1999 for routine immu
nization of US infants at 2,4, and 6 months of age.’4-’8In July 1999,
the use of rotavims vaccine in the United States was suspended
because of reports of intussusception among infants who received
the vaccine.19 Studies are ongoing to evaluate the association be
tween rotavirus vaccine and intussusception. Hospital discharge
data used can be used to study the epidemiology of intussusception
and other adverse events that might be associated with vaccines.
Our findings demonstrate the need for interventions against
rotavirus and other causes of childhood diarrhea and indicate that
hospital discharge data can be used to evaluate the effect of such
interventions. In view of the suspension ofuse ofrotavirus vaccines,
health care providers should encourage parents and caretakers to use
oral rehydration solutions (ORS) to prevent the development of
dehydration in children with diarrhea.20’Early and effective ORS
use should reduce childhood diarrhea hospitalizations caused by
rotavirus and other enteropathogens.
—
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Figure 3.—Monthly diarrhea-associated hospitalizations over time by
age group among children 1 month through 4 years of age in Hawaii,
1994 through 1997.
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Figure 4.— Composite monthly diarrhea-associated hospitalizations
among children 1 month through 4 years of age in Hawaii, by (A) age-
group and (B) etiology, 1994 through 1997. The proportion of monthly
hospitalizations is provided for each group separately.
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Studies show that damage from
the sun to a child’s skin can
actually increase the odds that
they will develop skin cancer
as adults. In fact, it is estimated
that 80% of a person’s total
lifetime sun exposure occurs
in the first 18 years of life. So
protect your children. Keep them
out of the sun during midday.
Cover them up. Give them hats.
And teach them to use sunscreen.
For more information, call
1-888-462-DERM, or visit
www.aad.org.
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